Showing 3191-3200 of 5621 results for "".
- Adaptive Biotechnologies and Microsoft Expand Partnership to Decode COVID-19 Immune Response and Provide Open Data Accesshttps://modernod.com/news/adaptive-biotechnologies-and-microsoft-expand-partnership-to-decode-covid-19-immune-response-and-provide-open-data-access/2477435/Adaptive Biotechnologies and Microsoft announced they will leverage their existing partnership mapping population-wide adaptive immune responses to diseases at scale to study COVID-19. Finding the relevant immune response signature may advance solutions to diagnose, treat and prevent the disease,
- President of Glaucoma Research Foundation Issues Messagehttps://modernod.com/news/president-of-glaucoma-research-foundation-issues-message/2477429/The Glaucoma Research Foundation sent an email to its membership on Friday, answering questions that glaucoma specialists may have during the COVID-19 pandemic. The letter reads: Dear Friends, Your health and well-being are on our minds as we all deal with a national and glob
- First-Phase Clinical Trials of China’s First Covid-19 Vaccine to Last Nine Monthshttps://modernod.com/news/first-phase-clinical-trials-of-chinas-first-covid-19-vaccine-to-last-nine-months/2477423/Clinical trials of China’s first inoculation for Covid-19 will run until Dec. 31 this year, according to data made public by the Chinese Clinical Trial Registry, as rep
- Keeping Your Vision Safe During a Natural Disasterhttps://modernod.com/news/keeping-your-vision-safe-during-a-natural-disaster/2477424/Parkhurst Nuvision in San Antonio, Texas, posted the following advisory to its patients, which providing tips for managing vision needs in an emergency. When faced with the forces of nature – in particular flooding and contaminated waters – people who rely on contact lenses to see well fa
- The Outpatient Ophthalmic Surgery Society (OOSS) Releases Statement Regarding COVID-19 Outbreakhttps://modernod.com/news/ooss-releases-statement-regarding-covid-19-outbreak/2477392/The Outpatient Ophthalmic Surgery Society (OOSS) has released a statement to its membership providing information and resources on how to establish ASC procedures if your community is directly affected by the COVID-19 outbreak. The statement reads: Dear Colleagues, In the cu
- Everads Therapy Enters Into Option Agreement to License Suprachoroidal Delivery System for Retinal Diseasehttps://modernod.com/news/everads-therapy-enters-into-option-agreement-to-license-suprachoroidal-delivery-system-for-retinal-disease/2477376/Everads Therapy announced that it has signed an option agreement with a large global pharmaceutical company, which will support the potential of its technology to overcome certain risks and side effects associated with current retinal disease treatment options, according to a company news release
- New Automated Method Developed for Corneal Nerve Fiber Tortuosity Analysishttps://modernod.com/news/new-automated-method-developed-for-corneal-nerve-fiber-tortuosity-analysis/2477369/The Intelligent Medical Imaging (iMED) Group at the Cixi Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering (CNITECH) of the Chinese Academy of Sciences proposed a fully automated method for image-level corneal nerve fiber tortuosity estimation, contribu
- Penn Medicine Study Finds Missing One Eye Appointment Can Lead to Vision Loss in Elderlyhttps://modernod.com/news/penn-medicine-study-finds-missing-one-eye-appointment-can-lead-to-vision-loss-in-elderly/2477319/A Penn Medicine study discovered that missing one ophthalmology appointment within a 2-year period could cause dec
- AbbVie-Allergan Deal Foes Try Again to Spur an FTC Crackdownhttps://modernod.com/news/abbvie-allergan-deal-foes-try-again-to-spur-an-ftc-crackdown/2477311/AbbVie and Allergan’s megamerger is likely in the final stages of review after the pair agreed to offload three drugs, including IL-23 hopeful brazikumab. But a cadre of union and consumer groups say that’s not enough—and they’re taking another stab at turning regulators against
- Santen: VISIONARY Study Demonstrates Effectiveness of Tafluprost/Timolol Combination Therapy in Open-Angle Glaucomahttps://modernod.com/news/santen-visionary-study-demonstrates-effectiveness-and-tolerability-of-tafluprost-timolol-combination-therapy-in-open-angle-glaucoma/2477305/Santen has announced that the results of its real world evidence study, VISIONARY, have been published in Advances in Therapy. The study, which was conducted in 12 countries from across Europe with up to 6-mo